General internal medicine.
Larson
E B
EB
University of Washington School of Medicine, Seattle, USA.
Sheffield
J V
JV
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007388:Internal Medicine / Q000639:trends*
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers